AMPH
Amphastar P
NASDAQ: AMPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$23.90
+2.18% today
Updated 2026-05-06
Market cap
$974.42M
P/E ratio
10.78
P/S ratio
1.35x
EPS (TTM)
$2.03
Dividend yield
—
52W range
$17 – $31
Volume
0.6M
Amphastar P (AMPH) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $118.36M | $204.32M | $229.68M | $210.46M | $251.52M | $255.16M | $240.18M | $294.67M | $322.36M | $349.85M | $437.77M | $498.99M | $644.39M | $731.97M | $719.89M |
| Revenue growth (YoY) | — | +72.6% | +12.4% | -8.4% | +19.5% | +1.4% | -5.9% | +22.7% | +9.4% | +8.5% | +25.1% | +14.0% | +29.1% | +13.6% | -1.7% |
| Cost of revenue | $90.25M | $114.02M | $142.72M | $159.21M | $174.17M | $150.98M | $149.38M | $187.68M | $190.43M | $206.51M | $238.03M | $250.13M | $293.27M | $358.11M | $363.83M |
| Gross profit | $28.10M | $90.30M | $86.96M | $51.26M | $77.35M | $104.19M | $90.80M | $106.98M | $131.92M | $143.34M | $199.74M | $248.86M | $351.12M | $373.86M | $356.06M |
| Gross margin | 23.7% | 44.2% | 37.9% | 24.4% | 30.8% | 40.8% | 37.8% | 36.3% | 40.9% | 41.0% | 45.6% | 49.9% | 54.5% | 51.1% | 49.5% |
| R&D | $31.05M | $31.16M | $33.02M | $28.43M | $37.06M | $41.20M | $43.41M | $57.56M | $68.85M | $67.23M | $60.93M | $74.77M | $73.74M | $73.91M | $85.84M |
| SG&A | $26.43M | $27.22M | $30.97M | $34.81M | $41.50M | $41.83M | $44.46M | $49.89M | $50.28M | $50.38M | $51.43M | $45.06M | $51.54M | $56.72M | $85.92M |
| Operating income | $-33.55M | $25.40M | $17.49M | $-17.98M | $-6.90M | $15.69M | $-895000.00 | $-8.62M | $-39000.00 | $10.95M | $69.89M | $107.50M | $196.99M | $205.42M | $140.40M |
| Operating margin | -28.3% | 12.4% | 7.6% | -8.5% | -2.7% | 6.1% | -0.4% | -2.9% | -0.0% | 3.1% | 16.0% | 21.5% | 30.6% | 28.1% | 19.5% |
| EBITDA | $-20.15M | $38.16M | $30.69M | $-3.09M | $3.88M | $30.26M | $11.90M | $7.89M | $21.08M | $30.19M | $111.56M | $146.16M | $240.29M | $277.31M | $149.10M |
| EBITDA margin | -17.0% | 18.7% | 13.4% | -1.5% | 1.5% | 11.9% | 5.0% | 2.7% | 6.5% | 8.6% | 25.5% | 29.3% | 37.3% | 37.9% | 20.7% |
| EBIT | $-31.30M | $26.66M | $17.62M | $-17.54M | $-9.38M | $15.69M | $-3.91M | $-8.62M | $-39000.00 | $5.01M | $85.02M | $117.89M | $198.52M | $220.11M | — |
| Interest expense | $584000.00 | $784000.00 | $958000.00 | $609000.00 | $987000.00 | $1.02M | $826000.00 | $243000.00 | $119000.00 | $374000.00 | $885000.00 | $1.85M | $27.16M | $30.34M | $25.48M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $7.75M | $18.09M | $11.86M | $-10.70M | $-2.79M | $10.53M | $4.51M | $-5.74M | $48.94M | $1.40M | $62.12M | $91.39M | $137.54M | $159.52M | $98.09M |
| Net income growth (YoY) | — | +133.4% | -34.4% | -190.2% | +74.0% | +477.9% | -57.2% | -227.3% | +952.9% | -97.1% | +4327.4% | +47.1% | +50.5% | +16.0% | -38.5% |
| Profit margin | 6.5% | 8.9% | 5.2% | -5.1% | -1.1% | 4.1% | 1.9% | -1.9% | 15.2% | 0.4% | 14.2% | 18.3% | 21.3% | 21.8% | 13.6% |